Susquehanna Issues Pessimistic Forecast for RXO (NYSE:RXO) Stock Price

RXO (NYSE:RXOFree Report) had its price target lowered by Susquehanna from $16.00 to $12.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a negative rating on the stock.

A number of other analysts have also recently commented on RXO. UBS Group upped their price target on shares of RXO from $22.00 to $31.00 and gave the company a “neutral” rating in a research report on Thursday, August 8th. Benchmark reaffirmed a “hold” rating on shares of RXO in a research note on Tuesday, October 15th. JPMorgan Chase & Co. boosted their price target on RXO from $25.00 to $26.00 and gave the company an “underweight” rating in a research note on Thursday, August 8th. TD Cowen increased their price target on RXO from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Thursday, August 8th. Finally, Wells Fargo & Company reiterated an “equal weight” rating and issued a $31.00 price objective on shares of RXO in a research note on Monday. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, RXO currently has an average rating of “Hold” and a consensus target price of $26.29.

View Our Latest Research Report on RXO

RXO Stock Down 1.3 %

RXO stock opened at $27.48 on Tuesday. The stock’s 50 day moving average is $27.84 and its 200 day moving average is $25.99. RXO has a one year low of $18.75 and a one year high of $32.82. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The firm had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $956.19 million. During the same quarter in the previous year, the company earned $0.05 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. On average, research analysts anticipate that RXO will post 0.12 EPS for the current fiscal year.

Hedge Funds Weigh In On RXO

Large investors have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC raised its stake in shares of RXO by 2,235.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock worth $80,000 after purchasing an additional 3,487 shares during the last quarter. Texas Permanent School Fund Corp lifted its stake in RXO by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 102,420 shares of the company’s stock valued at $2,240,000 after acquiring an additional 1,348 shares in the last quarter. SG Americas Securities LLC purchased a new position in RXO during the 1st quarter worth $151,000. Oppenheimer & Co. Inc. grew its stake in shares of RXO by 11.2% in the 1st quarter. Oppenheimer & Co. Inc. now owns 21,207 shares of the company’s stock worth $464,000 after acquiring an additional 2,138 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. raised its holdings in shares of RXO by 24.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 24,962 shares of the company’s stock valued at $546,000 after purchasing an additional 4,958 shares during the last quarter. Institutional investors own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.